121 results match your criteria: "Hospital for Skin and Venereal Diseases[Affiliation]"
Int J Dermatol
January 2025
1st Department of Dermatology and Venereology, National & Kapodistrian University of Athens, Medical School, "Andreas Sygros" Hospital for Skin Diseases, Athens, Greece.
Int J Dermatol
December 2024
1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
JAMA Dermatol
December 2024
Oncodermatology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.
Australas J Dermatol
December 2024
1st Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
J Eur Acad Dermatol Venereol
November 2024
1st Department of Dermatology and Venereology, School of Medicine, National and Kapodistrian University of Athens, "Andreas Syggros" Hospital for Skin and Venereal Diseases, Athens, Greece.
Arch Dermatol Res
October 2024
1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, I. Dragoumi 5, Athens, 161 21, Greece.
J Am Acad Dermatol
December 2024
First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.
Int J Mol Med
October 2024
Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.
Topical therapy remains a critical component in the management of immune‑mediated inflammatory dermatoses such as psoriasis and atopic dermatitis. In this field, macrolactam immunomodulators, including calcineurin and mammalian target of rapamycin inhibitors, can offer steroid‑free therapeutic alternatives. Despite their potential for skin‑selective treatment compared with topical corticosteroids, the physicochemical properties of these compounds, such as high lipophilicity and large molecular size, do not meet the criteria for efficient penetration into the skin, especially with conventional topical vehicles.
View Article and Find Full Text PDFInt J Dermatol
October 2024
1st Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
Melanoma Res
October 2024
First Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases.
We present a case of a 75-year-old male patient who experienced a severe exacerbation of his Kaposi sarcoma lesions, which have remained clinically stable for a year, following treatment with BRAF/mitogen-activated protein kinase inhibitors for his coexisting melanoma. In this case, we present the possibility that BRAF/MEK inhibition may be mechanistically associated with the progression of Kaposi sarcoma and briefly discuss the potential mechanisms behind this phenomenon.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
January 2025
Hemopathology Department, "Evangelismos" General Hospital, Athens, Greece.
Arch Dermatol Res
April 2024
Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
JAMA Dermatol
June 2024
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Dermatol Ther (Heidelb)
April 2024
Second Dermatology Department, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pharmaceuticals (Basel)
March 2024
Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University General Hospital 'Attikon', 12462 Athens, Greece.
Angiotensin-converting enzyme (ACE) inhibitors are used primarily in the treatment of hypertension, heart failure, and in the acute phase of myocardial infarction. Lisinopril [N-[(1S)-1-car-boxy-3-phenylpropyl]-L-lysyl-L-proline], enalapril [(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline] and ramipril [2-aza-bicyclo-[3.3.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
January 2025
1st Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
Am J Clin Dermatol
March 2024
Section of Dermatology and Venereology, Department of Medicine, University Hospital of Verona, Verona, Italy.
Background: Tuberculosis has a major global impact. Immunocompetent hosts usually control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI). Because TNF inhibitors increase the risk of tuberculosis reactivation, current guidelines recommend tuberculosis screening before starting any biologic drug, and chemoprophylaxis if LTBI is diagnosed.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
June 2024
1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
J Fungi (Basel)
June 2023
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Mass population movements have altered the epidemiology of tinea capitis (TC) in countries receiving refugees. Periodic monitoring of the local pathogen profiles may serve as a basis for both the selection of appropriate empirical antifungal therapy and the implementation of preventive actions. Therefore, we investigated the impact of an unprecedented immigration wave occurring in Greece since 2015 on the epidemiological trends of TC.
View Article and Find Full Text PDFDermatol Pract Concept
July 2023
First Department of Dermatology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Introduction: Melanoma of the lentigo maligna (LM) type is challenging. There is lack of consensus on the optimal diagnosis, treatment, and follow-up.
Objectives: To obtain general consensus on the diagnosis, treatment, and follow-up for LM.
Viruses
June 2023
National Public Health Organization, 15123 Athens, Greece.
In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022, and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation.
View Article and Find Full Text PDFMicroorganisms
May 2023
Department of Microbiology, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Str., 11527 Athens, Greece.
Background: Carbapenem-resistant (CRPA) is a life-threatening healthcare-associated infection affecting especially patients with immunosuppression and comorbidities. We investigated the association between the incidence of CRPA bacteremia, antibiotic consumption, and infection control measures in a hospital during 2013-2018.
Methods: We prospectively recorded the incidence of CRPA bacteremia, antibiotic consumption, use of hand-hygiene solutions, and isolation rates of multidrug-resistant (MDR) carrier patients.
Photodermatol Photoimmunol Photomed
September 2023
Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: Limited data on immune checkpoint inhibitor (ICI)-induced pruritus per se and efficacy of different therapeutic modalities in its management exist.
Objective: To study the quantitative and qualitative characteristics of ICI-induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.
Methods: We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.
Vaccines (Basel)
April 2023
1st Department of Dermatology and Venereology, Athens Medical School, "Andreas Syggros" Hospital for Skin and Venereal Diseases, National and Kapodistrian University, 15772 Athens, Greece.
J Eur Acad Dermatol Venereol
April 2023
First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.